Compare · CDRE vs ZBH
CDRE vs ZBH
Side-by-side comparison of Cadre Holdings Inc. (CDRE) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CDRE and ZBH operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ZBH is the larger of the two at $17.63B, about 14.2x CDRE ($1.24B).
- Over the past year, CDRE is down 9.9% and ZBH is down 1.6% - ZBH leads by 8.2 points.
- ZBH has hit the wire 11 times in the past 4 weeks while CDRE has been quiet.
- ZBH has more recent analyst coverage (25 ratings vs 12 for CDRE).
- Company
- Cadre Holdings Inc.
- Zimmer Biomet Holdings Inc.
- Price
- $29.07-3.74%
- $91.13-2.79%
- Market cap
- $1.24B
- $17.63B
- 1M return
- +1.11%
- +2.00%
- 1Y return
- -9.89%
- -1.64%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- 2021
- News (4w)
- 0
- 11
- Recent ratings
- 12
- 25
Cadre Holdings Inc.
Cadre Holdings, Inc. manufactures and distributes safety and survivability equipment that provides protection to users in hazardous or life-threatening situations. It primarily provides body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brands; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective and law enforcement equipment. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, and various foreign government agencies internationally. The company was incorporated in 2012 and is headquartered in Jacksonville, Florida.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest CDRE
- CEO AND CHAIRMAN Kanders Warren B sold $2,068,000 worth of shares (75,000 units at $27.57) (SEC Form 4)
- SEC Form 4 filed by Director Kissel Mary E.
- SEC Form 4 filed by Director Quigley William G Iii
- Amendment: SEC Form SCHEDULE 13D/A filed by Cadre Holdings Inc.
- SEC Form 4 filed by Director Norton Hamish
- SEC Form 4 filed by Director Sokolow Nicolas
- SEC Form 4 filed by CHIEF FINANCIAL OFFICER Browers Blaine
- SEC Form 4 filed by PRESIDENT Williams Brad
- SEC Form 4 filed by CEO AND CHAIRMAN Kanders Warren B
- CEO AND CHAIRMAN Kanders Warren B sold $6,539,000 worth of shares (225,000 units at $29.06) (SEC Form 4)
Latest ZBH
- Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
- Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
- BMO Capital Markets initiated coverage on Zimmer Biomet with a new price target
- SEC Form 4 filed by Director Hilado Maria Teresa
- SEC Form 4 filed by Director Kurdikar Devdatt
- SEC Form 4 filed by Director Hagemann Robert
- SEC Form 4 filed by Director Higgins Arthur J
- SEC Form 4 filed by Director Kolli Sreelakshmi
- SEC Form 4 filed by Director Farrell Michael J.
- SEC Form 4 filed by Director Shapiro Louis